Please see below for the information provided by the most recent meeting of the JFK Brokers Association on the FDA and their continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products, as was discussed at the July 18th JFK Quarterly Brokers Meeting.
FDA Contact info regarding this topic
FDA – Division of Northeast Imports
(CT, DC, DE, MA, MD, ME, NH, NJ, NY PA, RI, VA, WV)
- Dawne Hines, Program Division Director
- CAPT Nazmul Hassan, Director, Investigations Branch
- Anna Alexander, Director, Compliance Branch
NOTE:
- The status of an entry may be checked using the Import Trade Auxiliary Communication System (ITACS) at https://itacs.fda.gov
- This electronic mail box should be used to check on entries that are still in admissibility status. Our team will respond within 24 hours, excluding holidays and weekends. Entry Status email address: oraoeioneimpibstatus@fda.hhs.gov
- This electronic mail box should be used to check status on entries that have been detained and are with a Compliance Officer. A compliance officer will respond to the inquiry within 24 hours, excluding holidays and weekends. Compliance Status e-mail address: newyorkdetentionresponse@fda.hhs.gov
- Entry documents and electronic private laboratory analytical packages can be submitted using the Import Trade Auxiliary Communication System (ITACS) at https://itacs.fda.gov
- Electronic private laboratory analytical packages may also be submitted via email to the Compliance Officer listed on the FDA Notice of Action.
